The board of directors of Immunotech Biopharm Ltd. announced that with effect from 24 March 2023, Mr. Wang Ruihua and Mr. Yang Fan have been appointed as non-executive Directors. Mr. Wang Ruihua, aged 59, graduated from Hebei University of Science and Technology with a bachelor's degree in inorganic chemical engineering in 1983 and obtained a master's degree in accounting from the Chinese University of Hong Kong in 2007. Mr. Wang has over 39 years of experience in finance and business.

Since 2001, he has held a number of senior management positions in Tasly Pharmaceutical Group Co., Ltd, a company listed on the Shanghai Stock Exchange (stock code: 600535.SH) and currently serves as the chief financial officer of Tasly Biopharmaceuticals Co. Ltd. and the director of Tianjin Tasly (Liaoning) Pharmaceutical Co. Ltd., Shanxi Tasly Plant Pharmaceutical Co.

Ltd. and Tasly Chuangshijie (Tianjin) Biopharmaceutical Co. Ltd. From 1996 to 2001, he was the chief of finance of Tianjin Ripan Float Glass Co. Ltd. Prior to that, he has successively held various positions in Ministry of Chemical Industry Changsha Design and Research Institute, Qinhuangdao Glass Industry Research and Design Institute, and the SCIVIC Engineering Corporation.

Mr. Wang is a Chinese certified public accountant, a senior accountant and a certified asset appraiser in the People's Republic of China. Mr. Yang Fan, aged 42, graduated from Carleton University with a bachelor's degree in economic in 2004 and obtained a master's degree in business administration from Cheung Kong Graduate School of Business in 2012. He further obtained an executive master's degree of business administration from Guanghua School of Management of Peking University in 2020.

Mr. Yang has over 18 years of experience in corporate finance. Since 2016, he has held a number of senior management position in Tasly Financial Leasing Co. Ltd. and currently serves as its director and president.

From 2014 to 2016, he served as the executive director of the aviation investment division of China Minsheng Investment Co. Ltd. and the director of CM Luxembourg Investment S.A. Prior to that, Mr. Yang has held various senior and managerial positions in a number of financial leasing corporation and financial institutions. The Board further announces that Mr. Jung Hyun Chul ("Mr Jung") has resigned from his position as an executive Director and Mr. Lu Yuan ("Mr Lu") has resigned from his position as a non-executive Director with effect from 24 March 2023, due to their other personal commitments.